Straumann Holding AG
SIX:STMN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (49.7), the stock would be worth CHf110.89 (31% upside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 37.9 | CHf84.68 |
0%
|
| 3-Year Average | 49.7 | CHf110.89 |
+31%
|
| 5-Year Average | 50.9 | CHf113.63 |
+34%
|
| Industry Average | 37.1 | CHf82.91 |
-2%
|
| Country Average | 21.4 | CHf47.84 |
-44%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
CHf14.3B
|
/ |
Jan 2026
CHf355.9m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2026
CHf494.3m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2027
CHf589.6m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2028
CHf675.9m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2029
CHf782.4m
|
= |
|
|
CHf14.3B
|
/ |
Dec 2030
CHf828.8m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CH |
|
Straumann Holding AG
SIX:STMN
|
13.6B CHF | 37.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.2B USD | 60 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
158.3B USD | 25.2 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.3B USD | 38.6 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.9B USD | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
92B USD | 25.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
40B EUR | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 44.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.1B USD | 42.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
43.3B USD | 24.7 | |
| US |
|
Resmed Inc
NYSE:RMD
|
32B USD | 21.6 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 16.5 |
| Median | 21.4 |
| 70th Percentile | 29.9 |
| Max | 546 |
Other Multiples
Straumann Holding AG
Glance View
Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale. The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.